Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series

Annals of the rheumatic diseases

Volumn 76, Issue 12, 2017, Pages 2061-2064

  Kim, Sang Taek ^a   Tayar, Jean ^a   Trinh, Van Anh ^a   Suarez Almazor, Maria ^a   Garcia, Salvador ^a   Hwu, Patrick ^a   Johnson, Daniel Hartman ^a   Uemura, Marc ^a   Diab, Adi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

arthritis; DMARDs(biologic); inflammation; TNF alpha

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; TNF PROTEIN, HUMAN; TOCILIZUMAB; TUMOR NECROSIS FACTOR;

AGED; ANTAGONISTS AND INHIBITORS; ARTHRITIS; CASE REPORT; CELL CYCLE CHECKPOINT; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MALE; MIDDLE AGED; NEOPLASM; PROCEDURES; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS; CELL CYCLE CHECKPOINTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; MALE; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85037602354     PISSN: None     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2017-211560     Document Type: Article

References (0)